Drug intelligence / Profile preview

arginine glutamate

Development stage
Phase 4
Lead developer
Beijing YouAn Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Arginine glutamate** is a 1:1 amino-acid salt of L-arginine and L-glutamic acid administered as an intravenous injection for adjunctive management of hyperammonemia associated with chronic liver disease. Following intravenous administration, it dissociates into arginine and glutamic acid. Its ammonia-lowering activity is attributed to support of hepatic nitrogen disposal, including increased hepatic arginase activity and provision of arginine for urea-cycle ammonia detoxification. Chinese post-marketing clinical research has evaluated arginine glutamate injection in cirrhosis-associated mild hepatic encephalopathy versus L-ornithine-L-aspartate, with reported noninferiority for clinical improvement, ammonia reduction, and number connection test improvement. ([m-pharma.com.cn](https://www.m-pharma.com.cn/uploads/%E8%AF%B4%E6%98%8E%E4%B9%A6/11.%20%E7%B2%BE%E6%B0%A8%E9%85%B8%E8%B0%B7%E6%B0%A8%E9%85%B8%E6%B3%A8%E5%B0%84%E6%B6%B2%E8%AF%B4%E6%98%8E%E4%B9%A6.pdf))

Brand names
思瑞雪
Other names
L-arginine L-glutamatearginine glutamate saltglutamate arginine
02

Targets

GLUL (Glutamine synthetase)GluR (Glutamate receptors)NOS1 (nNOS)ARG1 (Arginase 1)

Beyond the preview

Go deeper on arginine glutamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arginine glutamate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call